A phase Ib/ II trial to assess the safety and efficacy of CXD101 in combination with the PD-1 inhibitor nivolumab in patients with metastatic, previously-treated, microsatellite-stable (MSS) colorectal carcinoma (short title CAROSELL)
| dc.contributor.author | Saunders, Mark P | |
| dc.contributor.author | Graham, J | |
| dc.contributor.author | Cunningham, D | |
| dc.contributor.author | Plummer, R | |
| dc.contributor.author | Cook, S | |
| dc.contributor.author | Church, D | |
| dc.contributor.author | Kerr, R | |
| dc.contributor.author | La Thangue, N | |
| dc.contributor.author | Kerr, DJ | |
| dc.date.accessioned | 2019-12-09T17:23:34Z | |
| dc.date.available | 2019-12-09T17:23:34Z | |
| dc.date.issued | 2019 | en |
| dc.identifier.citation | Saunders MP, Graham J, Cunningham D, Plummer R, Cook S, Church D, et al. 666TiP A phase Ib/ II trial to assess the safety and efficacy of CXD101 in combination with the PD-1 inhibitor nivolumab in patients with metastatic, previously-treated, microsatellite-stable (MSS) colorectal carcinoma (short title CAROSELL). Annals of Oncology. 2019;30(Supplement_5). | en |
| dc.identifier.doi | 10.1093/annonc/mdz246.143 | en |
| dc.identifier.uri | http://hdl.handle.net/10541/622611 | |
| dc.language.iso | en | en |
| dc.relation.url | https://dx.doi.org/10.1093/annonc/mdz246.143 | en |
| dc.title | A phase Ib/ II trial to assess the safety and efficacy of CXD101 in combination with the PD-1 inhibitor nivolumab in patients with metastatic, previously-treated, microsatellite-stable (MSS) colorectal carcinoma (short title CAROSELL) | en |
| dc.type | Meetings and Proceedings | en |
| dc.contributor.department | Oncology, The Christie NHS Foundation Trust, Oxford, UK | en |
| dc.identifier.journal | Annals of Oncology | en |
| refterms.dateFOA | 2020-01-22T20:08:30Z |
Files in this item
Name:
mdz246.143.pdf
Size:
80.27Kb
Format:
PDF
Description:
From UNPAYWALL. Conference abstract